Clinical trial
MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension…
NCT00449956 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00449956 |
|---|---|
| Title | MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED) |
| Official title | Multicenter, Double-Blind, Active Comparator-controlled Study to Evaluate the Safety and Efficacy of MK0507A in Patients With Glaucoma and Ocular Hypertension Who Are Inadequately Controlled on Beta-Blockers |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Glaucoma |
| Intervention type | Drug |
| Interventions | dorzolamide hydrochloride (+) timolol maleate, Comparator: timolol maleate, Comparator: dorzolamide hydrochloride |
| Enrollment | 474 |
| Start date | Mar 12, 2007 |
| Primary completion | Feb 16, 2008 |
| Completion | Feb 16, 2008 |
| First posted | Mar 21, 2007 |
| Last update posted | Jun 20, 2017 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: